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           It was recently reported the existence of a protein, called tricellulin (TRIC), 
concentrated at tricellular tight junctions (TJ) but also present at bicellular contacts. Most of 
the studies have fallen upon epithelial tissues and, despite the similar ectodermic origin of 
nervous tissue, TRIC presence in brain cells has never been reported. Interestingly, TRIC 
mRNA expression was found in mature dendritic cells, raising the question of whether TRIC 
is present in the brain resident immunocompetent cells, microglia. 
          Immunohistochemical, western blot and real-time PCR methodologies were used to 
investigate the expression of TRIC in the brain. TRIC expression was examined both in 
paraffin sections of human brain (hippocampus) and in human brain microvascular 
endothelial cells (HBMEC), either in primary culture (PC) or in a cell line (CL). We further 
investigated the TRIC expression in rat brain sections, in addition to PC of rat neurons and 
microglia. 
          Immunofluorescence analysis of the CL revealed the presence of the protein in 
HBMEC and highlighted that it is concentrated at tricellular contacts, though distributed along 
bicellular contacts as well. Western-blot analysis of HBMEC showed a 64-kDa band 
corresponding to a protein of the predicted size for TRIC, and the presence of mRNA for 
TRIC was confirmed by real-time PCR. The presence of TRIC in brain endothelium was 
corroborated by immunohistochemical analysis of paraffin sections of human and rat brain. 
TRIC was also investigated in PC of rat neurons and microglia. TRIC mRNA was detected in 
neurons and microglia, although the protein was not detected by western blot. Most 
interesting is the clear immunofluorescence staining for TRIC in microglia cytoplasm.  
          By revealing the presence of TRIC in HBMEC, as well as the protein occurrence in 
other than epithelial cells, this study shall have an important impact in the field of cerebral 
vascular biology and opens new avenues for future research, namely on the role of TRIC in 
nerve cells. 
 
Keywords: Neurovascular Unit; Neural cells; Brain microvascular endothelial cells; tight 
junctions; Tricellulin.  
RESUMO 
 
 
xvi 
          A barreira hemato-encefálica (BHE) é uma estrutura complexa e dinâmica que separa 
o sangue do encéfalo, e que possui um papel fundamental na manutenção da homeostase 
do sistema nervoso central (SNC). A BHE é constituída por uma monocamada de células 
endoteliais justapostas, que, juntamente com a membrana basal e as restantes células que 
compõem a unidade neurovascular (UNV), nomeadamente os pericitos, os astrócitos, os 
neurónios e a micróglia, conferem as propriedades bioquímicas, bem como a sua estrutura 
especializada. Nas células endoteliais encontram-se estruturas elaboradas, denominadas 
junções intercelulares de oclusão, que possuem um papel fundamental no controlo do efluxo 
e influxo de substâncias entre o SNC e a circulação sistémica. Estas junções intercelulares 
são compostas por proteínas de oclusão que promovem a adesão célula-a-célula, conferindo 
a característica semi-permeável da BHE.          
           As junções de oclusão presentes no contacto entre duas células são designadas por 
junções bicelulares, e as junções que se encontram no contacto entre três células são 
denominadas de junções tricelulares. A Tricelulina (TRIC) é uma nova proteína de oclusão, 
identificada recentemente como pertencendo às junções de oclusão tricelulares, por se 
encontrar predominantemente concentrada nos contactos tricelulares, apesar de também 
estar presente nas junções bicelulares. Esta proteína pertence à família das proteínas 
transmembranares, como a ocludina, possuindo cerca de 32% de homologia com a mesma. 
A maioria dos estudos sobre a tricelulina têm sido desenvolvidos em células epiteliais, nunca 
tendo sido investigada em tecido nervoso, apesar da sua origem ectodérmica. 
Recentemente, foi identificada a expressão de mRNA da TRIC em células dendríticas 
diferenciadas, levando a questionar se a TRIC poderá também estar presente nas células 
imunocompetentes do cérebro, nomeadamente na micróglia. Assim, este trabalho de 
mestrado foi delineado com o objectivo de explorar se a TRIC está presente no endotélio 
microvascular do cérebro e investigar se a TRIC se encontra em células nervosas, 
descriminando os tipos celulares que a expressam. 
          Para investigar a expressão da TRIC no cérebro foram utilizadas técnicas de 
imunohistoquímica, imunocitoquímica, western blot e PCR quantitativo em tempo real. A 
TRIC foi descrita como estando presente em vários tipos de células epiteliais, 
nomeadamente nas células da mucosa gástrica. Assim, iniciamos o nosso estudo em 
amostras de tecido gástrico, obtidas através de procedimentos cirúrgicos realizados no 
tratamento de patologias gástricas. A expressão da TRIC foi estudada em cortes histológicos 
de cérebro em parafina e em células endoteliais de capilares cerebrais humanos, quer em 
cultura primária, quer na linha celular utilizada no nosso laboratório. A expressão da proteína 
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foi também investigada em cortes histológicos de cérebro de rato, bem como em culturas 
primárias de micróglia e neurónios de rato.  
          A avaliação da presença da TRIC em cortes histológicos de estômago humano em 
parafina foi realizada através da técnica de imunohistoquímica. Os resultados obtidos 
demonstraram a expressão da proteína nas junções tricelulares e bicelulares das células 
epiteliais gástricas, assegurando assim que estavam estabelecidas as condições 
experimentais óptimas para a investigação da TRIC no cérebro. 
          Os resultados da imunofluorescência nas células da linha celular endotelial 
monstraram a presença da proteína nas células endoteliais dos capilares cerebrais humanos 
e que a mesma é expressa nos contactos tricelulares, encontrando-se presente também nas 
junções bicelulares. Os ensaios de western blot evidenciaram uma banda de 
aproximadamente 64-kDa, correspondente à proteína TRIC. A expressão de mRNA foi 
também confirmada pela técnica de PCR quantitativo em tempo real. Os resultados de 
western blot e PCR obtidos para as células endoteliais da linha celular foram confirmados 
pelos das células da cultura primária, mas demonstram diferenças no nível da expressão, 
quer da proteína, quer do mRNA. Com esta técnica pareceu haver uma diminuição de 
expressão de aproximadamente 20-30% nas células endotelias da cultura primária, quando 
comparada com as células da linha celular. Este resultado pode ser justificado pela 
heterogeneidade das células, bem como das respectivas culturas. A presença de TRIC no 
endotélio dos capilares do cérebro foi corroborada através de estudos in situ feitos em cortes 
histológicos de rato, utilizando a técnica de imunohistoquímica. Interessantemente, os 
resultados evidenciaram também a expressão de TRIC nas junções tricelulares e bicelulares 
das células do plexo coroideu, o que seria esperado, uma vez que está descrita a presença 
de junções intercelulares nessas células que compõem a barreira sangue-líquido céfalo-
raquidiano. Os resultados da técnica de imunofluorescência nos cortes histológicos de 
hipocampo humano estão de acordo com os resultados obtidos para rato. Efectivamente, os 
a análise in situ evidenciou a expressão da TRIC nas junções intercelulares das células 
endoteliais dos capilares cerebrais.  
          Apesar de se saber que a BHE envolve diferentes tipos de células, até hoje não foi 
estudada a presença da TRIC nas células neuronais e não neuronais do cérebro. Assim 
sendo, no presente trabalho foi estudada também a presença da TRIC em outros tipos de 
células que não as endoteliais, mais especificamente nos neurónios e na micróglia. A 
expressão de mRNA foi evidenciada em todas as amostras, parecendo haver uma menor 
expressão nos neurónios e na micróglia, quando comparada com as células endoteliais da 
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linha celular (aproximadamente 7% e 3%, respectivamente). De facto, a presença de 
proteínas de oclusão, como as claudinas e a ocludina, já foram reportadas em culturas 
primárias de neurónios e astrócitos. Para além disso, está descrita a presença das mesmas 
em cérebro humano, e sendo a TRIC uma proteína de oclusão da família da ocludina, a 
presença da mesma nos neurónios é um resultado provável. O mais interessante é o 
resultado da imunofluorescência na micróglia, que evidencia a expressão da proteína no 
citoplasma dessas células, sugerindo que a TRIC, de alguma forma, contribui para o sistema 
imune do cérebro. De facto, há estudos que descrevem a presença de TRIC, para além de 
outras proteínas de junção intercelular, em células dendríticas diferenciadas, as quais fazem 
parte do sistema imunitário. Existem ainda estudos que sugerem que as células 
imunocompetentes do cérebro, nomeadamente a micróglia, derivam da linhagem monocítica.  
          Inesperadamente, não foi verificada a expressão da proteína nos neurónios. Uma 
possível explicação é o facto de não haver expressão proteica suficiente para que possa ser 
detectada por western blot e imunofluorescência. Por outro lado, duas outras hipóteses 
devem ser consideradas: haver expressão da proteína apenas em algumas circunstâncias, 
ou não haver, de todo, expressão proteica. De facto, há estudos que sugerem que a ocludina 
e a TRIC têm origem no mesmo gene, o qual duplicou ao longo da evolução filogenética, e 
tendo em conta também a presença de ocludina nos neurónios, é provável haver expressão 
de mRNA da TRIC nessas células. No entanto, é possível que haja expressão do mRNA 
sem necessariamente ocorrer a tradução do mesmo. Ainda assim, esta ausência de 
expressão poderá ser ultrapassada em situações pontuais, nomeadamente em patologias do 
SNC, em que ocorre sobre-expressão de proteínas de oclusão, como as claudinas e a 
ocludina. Reunindo estes dados com os resultados do presente estudo, talvez possamos 
especular que a função da TRIC esteja relacionada com a preservação da BHE. No entanto, 
são necessários mais estudos para completar os resultados obtidos.  
          Concluindo, este estudo revela pela primeira vez a presença da TRIC no endotélio dos 
capilares cerebrais humanos, indicando que esta proteína faz parte das junções 
intercelulares, contribuindo assim para a função de barreira entre o sangue e o encéfalo. O 
presente estudo demonstra também pela primeira vez a presença da TRIC em células não 
epiteliais e abre novos caminhos para estudos futuros, nomeadamente qual o papel da TRIC 
nas células nervosas.  
 
Palavras-chave: Barreira hemato-encefálica; Unidade Neurovascular; Células endoteliais 
dos capilares cerebrais; Junções intercelulares de oclusão; Tricelulina. 
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           The blood–brain barrier (BBB), a dynamic and complex interface between the blood 
and the central nervous system (CNS), was first identified in 1883 by Paul Ehrlich. The BBB 
plays a critical role in maintaining the stability of the CNS microenvironment (Li et al., 2010). 
The BBB function is therefore best described as a physical and metabolic barrier with 
selective transport systems acting as a signaling interface between brain and blood (Carvey 
et al., 2009). The specific structural and biochemical properties of the BBB arise from existent 
layers between the blood and the brain and from interactions between large varieties of cell 
types (Bernas et al., 2009).  
          Endothelial cells (EC) of brain microvessel walls, whose apposing plasma membranes 
form tight junctions (TJs) that physically limit the paracellular passage to water and solutes 
between the blood and the brain (Romero et al., 2003) form the anatomic basis of the BBB 
(Cardoso et al., 2010). Together with neurons, microglia, astrocytes, as well as perivascular 
pericytes, there is a construct called the neurovascular unit (NVU) (Fig. 1), essential for both 
health and function of the CNS (Hawkins and Davis, 2005; Persidsky et al., 2006). In fact, the 
disruption of the BBB integrity has been shown to occur in many neurological disorders, such 
as Alzheimer's disease, stroke and HIV-1 encephalopathy (Huber et al., 2001; Petty and Lo, 
2002), and it was recently proposed that BBB impairment contributes to the onset and 
progression of some neurologic disorders (Zlokovik, 2008). 
 
Fig. 1. Simplified representation of the neurovascular unit. The brain microvessel wall consists of endothelial cells, 
whose apposing plasma membranes form tight junctions that seals aqueous paracellular diffusional pathway 
between the cells. Pericytes are adjacent to capillaries and share a common basement membrane with endothelial 
cells. Astrocyte endfeet form a lacework of fine lamellae closely apposed to the outer surface of the BBB 
endothelium and respective basement membrane. Astrocytes have a close relationship with neurons which 
innervate the endothelial cells and astrocytic processes. Microglia, another cell type with close contact with 
capillaries is the immunocompetent resident cells of the brain.  
 
INTRODUCTION 
  
 
2 
1.1. Neurovascular unit  
1. 1. 2. Neurons  
          There is some evidence that neurons can regulate the function of blood vessels in 
response to metabolic requirements by inducing expression of enzymes unique for brain 
microvascular endothelial cells (BMEC) (Persidsky et al., 2006). However, little is known 
about the role that neurons have on BBB phenotype. BMEC and astrocyte processes are 
directly innervated by neurotransmitters, suggesting their potential involvement in BBB 
regulation (Choin and Kim, 2008; Carvey et al., 2009). As neuronal function is heterogeneous 
throughout the brain, it follows that brain microvascular endothelia cells (BMEC) function, as 
well as BBB integrity and function are heterogeneous in the brain (Carvey et al., 2009). 
1. 1. 3.  Microglia 
          Microglia, another cell type in close contact with cerebral blood vessels (Cardoso et al., 
2010;Correale and Villa, 2009), reside within the CNS parenchyma (Streit, 2002) and engage 
several important roles in the developing brain (Cuadros and Navascues, 1998; Kim and de 
Vellis, 2005), as well as in pathological conditions (Block and Hong, 2005; Nakajima and 
Kohsaka, 2004). Microglia are responsible for the immune surveillance and innate immune 
response in the brain and proliferate early in the embryonic environment, although most 
authors believe that these cells derive from the monocyte/macrophage lineage (Alliot et al., 
1999; Chan et al., 2007). These cells present themselves in two forms, resting and activated 
microglia, changing the phenotype in response to homeostatic disturbance of the CNS. When 
resting, cells have small bodies and long thin process. Activated microglia, what are called 
“reactive microglia”, display a complexity of phenotypic alterations and assume a phagocytic 
morphology (Zlokovic, 2008). These cells interact with BMEC, which is thought to contribute 
to the BBB properties (Choin and Kim, 2008).  
1. 1. 4.  Astrocytes  
          Astrocytes are glial cells whose end-feet engulf the capillary networks of the brain 
(Abbot, 2002) that have long been assumed to significantly influence neurovascular structure 
and integrity. This is underscored by the close apposition of the astrocytic end-feet on the 
capillary walls and their close relationship with neurons. Thus, astrocytes are in a position to 
disperse vascular nutrients away from the vessels in support of neural function. They also 
induce and modulate the development of the BBB and BMEC unique phenotype, enhancing 
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TJ and reducing gap junctional area (Abbot et al., 2006). In vitro studies suggest that BMEC 
grown in the presence of astrocytes or astrocyte conditioned media increases endothelial 
cells (EC) resistance and increases expression of TJ proteins (Abbott, 2002; Cardoso et al., 
2010; Deli, 2009).  
          Recent studies by Carvey et al., (2009) suggest that elements of the basement 
membrane contributed by the astrocyte may participate in TJ formation by stabilizing the 
BMEC and inducing protein expression changes in the BMEC It is therefore more likely that 
interactions among the BMEC, astrocytes, pericytes and the basement membrane are all 
required to initiate complete TJ formation (Carvey et al., 2009). 
1. 1. 5.  Pericytes 
          In addition to BMEC, the pericytes is thought to be a critical component of a functional 
BBB, although we know little about it. Pericytes are vascular cells adjacent to capillaries that 
share a common basement membrane with EC and have many cytoplasmic process 
encircling capillaries (Shepro and Morel, 1993). These cells are sprinkled along the vascular 
endothelium in microvascular networks and form gap junctions with BMEC suggesting an 
intimate functional relationship (Fisher, 2009). Pericytes also communicate with other 
elements of the NVU through signaling pathways (Nakaoke et al., 2007). These actin-
expressing cells have a number of vasoactive signaling receptors and release laminal 
proteins, suggesting their involvement in microvascular capillary flow and in the differentiation 
of the BBB (Dore-Duffy et al., 2006). Association of pericytes with microvascular endothelia is 
essential to maintain structural and junctional integrity (Braun et al., 2007). Products from 
pericytes may also be involved in initiating TJ formation (Kim et al., 2009) and both pericytes 
and EC shareTJs, adhesion plaques and soluble factors (Bagley et al., 2005).  
1. 1. 6.  Endothelial cells.  
          The cerebral endothelium forms the basis of the BBB in mammals and higher 
vertebrates (Hawkins et al., 2006) and the capillaries make up the primary part of the BBB 
(Khan, 2005). Electron microscopy studies of the BBB have identified distinct morphologic 
and metabolic characteristics of these particular EC, different to those present in peripheral 
tissues (Brightman and Reese, 1969; Lane et al., 1992).  BMEC are characterized by the 
absence of fenestrations, a low level of pinocytic vesicles and elaborate junctional complexes 
that eliminate gaps or spaces between cells. Therefore, endothelial cell monolayers prevent 
any free diffusion of blood-borne substances into the brain parenchyma (Carvey et al., 2009; 
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Chaudhuri, 2000; Zlokovic, 2008). Moreover, emdothelial cells display high transendothelial 
electrical resistance and cause severe restriction of the paracellular pathway for diffusion of 
hydrophilic solutes (Abbott, 2002). However, essential nutrients and other compounds are 
able to cross into the CNS by using specific membrane transporter systems (de Boer and 
Gaillard, 2006). The presence of elaborated junctional complexes that includes mainly TJ and 
adherens junction (AJ) proteins characterizes the cerebral microvasculature lining (Cardoso 
et al., 2010; Zlokovic, 2008). 
2. Intercellular junctions 
          An important property of epithelial and EC is their assembly into a physical, and ion- 
and size-selective barrier separating tissues (Niessen, 2007). In mammals, there are 
elaborate structures composed of integral membrane proteins (Chiba et al., 2008; Krause et 
al., 2008), linker or adaptor proteins connecting them to the actin cytoskeleton, and signalling 
molecules (Paris et al., 2008), which form the intercellular junctions. Among these are 
included AJ and TJ, which play a crucial role in the formation and maintenance of epithelial 
and endothelial barriers (Niessen, 2007). While in epithelial barriers AJ are situated in the 
apical junctional complex in basolateral direction from the TJs, in brain EC TJs and AJ are 
intermingled (Vorbrodt et al., 2004). Another identified function of intercellular junctions is that 
they provide the cell not only with structural integrity but also function as landmarks, spatially 
confining signaling molecules and polarity cues as well as serving as docking sites for 
vesicles (Nelson, 2003).  
2. 1. Tight junctions 
          TJ are networks of transmembrane proteins that are responsible for the barrier 
properties. These elaborate structures located on the apical region of EC, function as a seal 
that regulates lateral diffusion between the apical and basolateral plasma membrane 
domains, forming a semi-permeable barrier to paracellular flux (Cardoso et al., 2010; 
Hawkins and Davis, 2005; Hawkins and Egleton, 2006; Persidisky et al., 2006). Claudins, 
occludin (marvelD1), tricellulin (marvelD2), marvelD3 and junctional adhesion molecules 
(JAM) are integral membrane proteins interacting with those of neighbouring plasma 
membrane and forming a barrier. The transmembrane proteins of the TJ are often grouped 
according to the number of times they span the plasma membrane: JAM is a single-pass 
transmembrane protein, while occludin, claudins, tricellulin (TRIC) and marvelD3 are four-
pass (Cardoso et al., 2010). The function of some of these proteins in epithelial barrier, their 
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relevance in cellular and epithelial differentiation, as well in infections and inflammatory 
diseases have been defined in recent years (Michels et al., 2009; Reuter et al., 2009; 
Schulzke and Fromm, 2009; Sonoda et al., 1999; Watson et al., 2009). 
2. 1. 1. Tight junction proteins 
2. 1. 1. 1. Occludin 
          Occludin was the first component of TJ to be identified (Furuse et al., 1993). Occludin 
is associated with intramembranous strands, although it is not required for their assembly 
(Balda and Matter, 2008). It is a 60-kDa protein that modulates the barrier function, but 
disruption of occludin expression does not affect TJ structure (Du et al., 2010; Yu et al., 
2005). This TJ is highly expressed and consistently stains in a distinct continuous pattern 
along the cell margins in the cerebral endothelium, whereas it is much more sparsely 
distributed in non-neural endothelium (Hawkis and Davis, 2005). One of its N- and C-terminal 
cytosolic domains is sufficient to anchor the protein in the junction and to ensure a continuous 
junctional distribution, but they have different functional properties. The N-terminal domain 
regulates neutrophil transmigration and the C-terminal domain regulates the paracellular 
diffusion and target the occludin to the basolateral membrane, connecting then to the 
cytoskeleton via accessory proteins zonula occludens (ZO)-1, ZO-2 and ZO-3 and is thought 
to interact with a ubiquitin ligase (Deli et al., 2010; Shimizu et al., 2008). Occludin can also 
recruit signal transduction molecules to TJ (Du et al., 2010). However, the underlying 
molecular mechanisms of many of the processes to which occludin has been linked remain to 
be determined and the functional relevance of most of its biochemical interactions is still 
unknown. (Deli et al. 2008) 
2. 1. 1. 2. Claudins 
          Claudins, from Latin word “claudere” meaning to close was identified as a major 
constituent of bTJ strands. There are 24 distinct claudin family members that have been 
described in vertebrates (Furuse et al., 1998). Claudins range in size from 20 to 34-kDa and 
are integral membrane proteins that share four transmembrane domains of occludin, but do 
not contain any sequence homology to occludin (Wolburg and Lippoldt, 2002; Ikenouchi et 
al., 2005). In vitro studies have shown that claudins are capable of inducing the formation of 
TJ and that individual claudins vary in their ability to form a tight or leaky barrier (Furuse et 
al., 1998). Claudin-1, -2, -3, -5, -11, -12 and -18 are the only claudins family proteins that 
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were detected in mammalian BMEC (Petty and Lo, 2002; Bélanger et al., 2007; Krause et 
al.,2008; Mahajan et al., 2008; Neuhaus et al., 2008.; Romanitan et al., 2009). 
          Claudin-1 and claudin-5 are associated with maintance of normal BBB function 
(Vorbrodt and Dobrogowska, 2003) and thought to be important in angiogenesis (Wolburg 
and Lippoldt, 2002). It was also suggested that extracellular loops of claudins create charge-
selective paracellular aqueous pores that permit the passive diffusion of ions between cells 
(Krause et al., 2008; Van Itallie and Anderson, 2006). However, structural evidence for such 
pores is still missing. 
2. 1. 1. 3. JAM 
          JAM, another integral membrane protein of TJ family, is involved in intercellular 
adhesion between the cells of barriers, as well as in adhesion between barriers and cells of 
immune system (Chiba et al., 2008; Paris et al., 2008). JAM proteins are members of the 
immunoglobulin superfamily and consist of JAM-1, JAM-2 and JAM-3. These adhesion 
molecules have 40-kDa and are expressed in TJ of EC (Vorbrodt and Dobrogowska, 2003). 
While JAM-1 is involved in tight junctional structure organization of cell-to-cell and contributes 
to barrier function and cell polarity in epithelial and EC, JAM-2 and JAM-3 interact each other 
and participates in spermatogenesis (Chiba et al., 2008). In addition, both JAM-2 and JAM-3 
control leucocytes transmigration (Ogasawara et al., 2009; Stamatovic et al., 2008), another 
important aspect of barrier functions.  
2. 1. 1. 4. MarvelD3 
          MarvelD3 is a third TJ-associated MARVEL domain protein (contains a conserved four-
transmembrane MARVEL domain – MAL and related proteins for vesicle trafficking and 
membrane link). It is located on chromosome 16 and expressed by all vertebrates. Steed et al 
(2009) identified this novel protein by phylogenetic studies, RNA and immunofluorescence 
analysis. 
          It is known that this novel TJ protein is expressed as two isoforms (Steed et al., 2009) 
and is present in both bicellular and tricellular contacts (Raleigh et al., 2010). It is thought that 
marvelD3 is not essential for junction assembly and formation of a functional paracellular 
diffusion barrier. On the other hand, it is a determinant of paracellular ion permeability (Steed 
et al., 2009), but the mechanisms responsible for that property have to be identified. In 
addition, marvelD3 is able to partially compensate for occludin or TRIC loss but, they do not 
complement one another functionally (Raleigh et al., 2010). Maybe structural differences are 
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responsible for that. In fact, the C- and N-terminal cytoplasmic domains of marvelD3 do not 
have the elogation factor RNA polymerase II (ELL) domain (Raleigh et al., 2010), which is 
present in both domains of occludin and TRIC and are important as an elongation factor that 
can increase the catalytic rate of RNA polymerase II transcription by suppressing transient 
pausing by polymerase (Zhou et al., 2009). Furthermore, the C-terminal domain is not able to 
interact with ZO-1. In contrast, the N-terminal domain is long and might provide a regulatory 
function (Raleigh et al., 2010; Steed et al., 2009). Together with occludin and TRIC proteins, 
marvelD3 constitute the complete TAMP (Tight junction Associate Marvel Protein) sub family 
of MARVEL proteins, contributing to epithelial regulation in a distinct way (Raleigh et al., 
2010).  
2. 1. 1. 5. Zonula occludens 
          TJ are formed by not only the integral membrane proteins occludins, claudins, JAMs, 
TRIC and marvelD3, but also many peripheral membrane proteins, including the cytoplasmic 
TJ accessory proteins, such as zonula occludens-1, -2 and -3 (ZO-1, ZO-2, ZO-3, 
respectively), which interact with each other and connect integral proteins to the actin 
cytoskeleton (Lee et al., 2004; Schulzke and Fromm, 2009). All these have in common the 
presence of a SH3 (Src homology 3) domain, a guanylate kinase homology (GK) domain 
(Anderson et al., 1995), and at least one PDZ (Post-synaptic density 95, Disk-large and ZO-1 
proteins) domain, which recruit signaling proteins (McGee et al., 2001). It is a membrane-
associated guanylate kinase protein (MAGUK‟s – modular scaffolds that organize signaling 
complexes at synapses and other cell junctions.), a submembranous TJ-associated protein 
(Persidisky et al., 2006) that plays a central role in the macromolecular assembly of TJ by 
interacting with integral proteins of the membrane of adjoining cells (Schulzke and Fromm, 
2009), with the actin cytoskeleton, and with nuclear factors (Wolburg et al., 2009). 
           Human ZO-1, the first TJ-associated protein identified and characterized, is a 220-kDa 
phosphoprotein mostly expressed in endothelial and epithelial cells (Kniesel and Wolburg, 
2000). In some specialized endothelia it is expressed as variable amounts of two related 
isoforms, which originate from the alternatively spliced mRNA transcripts α+ and α– (Ciana et 
al., 2010) and whose specific differential role is still unknown. This protein is not only a 
structural protein, but also a nuclear factor influencing gene expression (Wolburg et al., 
2009). Loss or dissociation of ZO-1 from the junctional complexes is associated with 
increased barrier permeability (Choin and Kim, 2008). ZO-2 binds to the transmembranous 
proteins of the TJ and transcription factors (Persidisky et al., 2006) and ZO-3 binds occludin 
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and ZO-1 directly, but not ZO-2 (Kniesel and Wolburg, 2000). Furthermore, ZO-1, ZO-2 and 
ZO-3 form a protein complex that can be involved in cadherin-based cell adhesion through 
their binding to catenin and actin filaments (Deli, 2009). 
2. 1. 2. Types of tight junctions 
           TJ between two adjacent cells are called bicellular TJ (bTJ) whereas at tricellular 
contacts, where there are three epithelial cells meeting together, there is a structurally 
specialized organization, named as tricellular TJ (tTJ) (Ikenouchi et al., 2005). Claudins, 
occludin, JAM and MarvelD3 are proteins expressed at bicellular contacts. Therefore, 
claudins, occludin (Ikenouchi et al., 2005; Ikenouchi et al., 2008) and marvelD3 are also 
found in tTJ (Raleigh et al., 2010). These specialized structures were first observed between 
three plasma membranes by freeze-fracture electron microscopy (Friend and Gilula 1972; 
Staehelin et al. 1969; Staehelin 1973; Wade and Karnovsky 1974). tTJ consist of isolated 
sets of paired strands, which have an orientation parallel to the longitudinal axles of epithelial 
cells and perpendicular to the main orientation of the bicellular tight-junctional belt. At tTJ, the 
most apical elements of the horizontal TJ strands from both sides attach and turn together to 
extend vertically in the basal direction and strands of bTJ and tTJ interconnect and form one 
continuous complex (Staehelin, 1974). As a result, forms a vertically orientated triple pair 
strand structure with a 10 nm “central tube” (Staehelin, 1973; Wade and Karnovsky, 1974; 
Walker et al., 1994). Recently, TRIC was identified as a tricelular TJ protein located where 
tree cells meet (Ikenouchi et al, 2005). 
3. Tricellulin 
3. 1. Discovery and known localization 
           It was recently reported by Ikenouchi et al. (2005) the existence of a special protein of 
the occludin type, called TRIC at „„three corner‟‟ contact sites of simple epithelial cells of 
intestine, stomach and kidney, either in monolayer cell cultures or in situ. In line with the 
findings obtained by Ikenouchi and colleagues in mouse and dog species, we detected the 
presence of the protein at tricellular contacts between epithelial cells, as well as in immune 
cells, of the human stomach. Other studies, performed by Schlüter et al. (2007), 
demonstrated the presence of TRIC in epidermal and other stratified epithelial cells. 
          TRIC was the first protein found to be concentrated at tricellular contacts in vertebrates. 
In   Drosophila melanogaster, was identified gliotactin, a single membrane-spanning protein, 
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also located at tricellular contacts (Schülte et al., 2003), although these two proteins do not 
show any sequence similarity. TRIC is a tetraspan protein that is concentrated at the 
vertically oriented TJ strands of tricellular contacts of epithelial cell sheets, and contains four 
transmembrane domains with N- and C-terminal cytoplasmic tails, two extracelluar loops and 
a short intracellular loop between transmembrane domains 2 and 3 (Fig. 2.) 
 
Fig. 2. Simplified model of tricellulin (TRIC) structure and membrane folding. TRIC is a four-pass transmembrane 
protein, with two extracellular loops, the first with 41 aminoacids (aa) and the second with 30 aa, a short 
intracellular loop between transmembrane domains, a N-terminal cytoplasmatic domain with 187 aa and a C-
terminal that contains 193 aa. TRIC shares some homology with occludin, which has a shorter N-terminal (61 aa) 
and a longer C-terminal domain (259 aa). 
3. 2. Tricellulin regulation 
          It was referred by Ikenouchi et al. (2005) that the TRIC C-terminus has 32% homology 
with occludin. In fact, TRIC and occludin are located in tandem on human chromosome 5 and 
it has been speculated that they may have arisen from gene duplication during phylogenetic 
evolution (Steed et al., 2009). However, despite this homology, occludin and TRIC are 
differentially phosphorylated in their C-terminal tails: they differ in respect to serine/threonine 
casein kinases CK1- and CK2-mediated phosphorylation (Dörfel et al., 2009). TRIC C-
terminus is not targeted by either of these kinases but also could not detect binding of the 
kinases to the TRIC C-terminal domain. These observations can be correlated not only with a 
distinct localization of protein kinase bind, but also differences in the regulation of TRIC 
function (Dörfel et al., 2009). Protein kinase C (PKC) signal transduction pathways are known 
to regulate epithelial barrier function via TJ (Tsukamoto et al., 1999). Phosphorylation of TJ 
proteins appears to play a central role in the regulation of TJ assembly and function. Different 
Ser/Thr- and Tyr-kinases have been identified as kinases that phosphorylate TJ components 
under different conditions and affect formation and stability of TJ and in consequence 
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modulate barrier function and permeability properties (Feldman et al., 2005; González-
Mariscal et al., 2008). Furthermore, it is known that when infective agents, free radicals, 
vasogenic agents and lipid mediators binds to respective receptors on the endothelial 
surfaces, signaling cascades are actived: protein kinases RhoA/Rho (ROCK) and mitogen-
activated protein kinases (MAPK) are related with phosphorylation of TJs and AJ that cause 
the junction complex to dissociate from its cytoskeleton anchor, which leads to a weakened 
cell-cell adhesion (Cardoso et al., 2010). 
          According to a recent publication by Westphal et al. (2010), a crosstalk between TRIC 
and occludin appears to exist, involving formation and organization of TJ strands. It was 
reported that in Madin-Darby canine kidney (MDCK) cell line, the TRIC C-terminal is 
important for the basolateral translocation of TRIC, whereas the N-terminal domain appears 
to be involved in directing TRIC to tricellular contacts. These observations differ from data 
reported by Ikenouchi et al. (2008) who showed that with both C- and N-terminal domains 
deleted, TRIC colocalize with claudin-1 at the cell surface. Westphal et al. (2010) 
demonstrated that the transport to the cell surface of TRIC with a deleted C-terminal domain 
was impaired and more intracellular aggregates were detectable. In contrast, the transport to 
the cell surface of TRIC with a deleted N-terminal domain was efficient. In addition, a 
construct with both C- and N-terminal domains deleted did not translocate TRIC to the cell 
surface and accumulated in intracellular aggregates (Ikenouchi et al., 2008; Westphal et al., 
2010).  
          Homomeric TRIC-TRIC and heteromeric TRIC-occludin complexes were identified 
suggesting that both proteins are transported together to the edges of elongating bicellular 
junctions and get separated when tricellular contacts are formed. In this respect, it was 
assumed that homomeric interactions can form within endoplasmatic reticules and/or Golgi 
apparatus during the biosynthetic transport of the protein to the cell surface (Westphal et al., 
2010). In addition with detected heteromeric TRIC-occludin complexes, Westphal et al. 
(2010) extend the mechanism for the tricellular localization of TRIC previously postulated by 
Ikenouchi et al. (2008). TRIC and occludin share a common transport pathway directing both 
proteins to elongation edges: TRIC and occludin form complexes in initial phases when they 
arrive at TJ and then separate when established tricellular contacts (Fig. 3). 
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Fig. 3. Schematic model for tricellulin (TRIC) localization and regulation. (1) Protein kinase C (PKC) signal 
transduction pathway is involved in regulation of tight junctions (TJ), including TRIC. Zonula occludens proteins 
(ZO-1, ZO-2 and ZO-3) interact with each other connect TRIC to actin cytoskeleton and recruit signaling proteins. 
Homomeric TRIC-TRIC complexes in endoplasmatic reticules and/or Golgi apparatus during TRIC (red) protein 
biosynthetic transport to the cell surface. Heteromeric TRIC-occludin (green) interactions in initial phases when 
they arrive at TJ. (2) Then separate when established tricellular contacts (3) and TRIC interact with another TRIC 
protein of opposed membrane. 
 
           Phosphorylation of TJ proteins appears to play a role in these regulations. In contrast 
with these data, another study reported that TRIC and occludin do not physically interact or 
that association is either unstable or uncommon, but shows an interaction between TRIC and 
marvelD3 and both occludin and marvelD3 (Raleigh et al., 2010). However, the same study 
shows that both TRIC and occludin mobilities were similar at bicellular and tricellular regions 
and they also hypothesized that TRIC and marvelD3 are delivered to the TJ immediately after 
synthesis, and in contrast, occludin and claudin-1 are redistributed from cytoplasmic stores to 
the TJ during barrier development.  
3. 3. Tricellulin function 
          Knockdown of TRIC provided the first insight into the function of this protein. The loss 
of TRIC severely affected TJ organization, not only at tricellular contacts, but also bTJ were 
disorganized resulting in disturbed continuity of occludin distribution at bTJ with tear-drop-
shaped accumulation of occludin at tTJ (Ikenouchi et al., 2008.On the other hand, in occludin 
knockdown MDCK cells, TRIC is mislocated to bTJ, probably to compensate occludin 
function (Ikenouchi et al., 2008). From these observations, it was concluded that in occludin 
knockout mice, TRIC may compensate at least for some of the occludin functions (Ikenouchi 
et al., 2005; Ikenouchi, et al., 2008). Consistent with this, TRIC and marvelD3 proteins 
increased in response to in vivo tumor necrosis factor (TNF) treatment; however, while 
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occludin was redistributed into cytoplasmic vesicles, TRIC was enriched at bicellular and 
tricellular TJ, as well as within the cytoplasm (Raleigh et al., 2010).  
          While TRIC knockdown affected TJ organization, its overexpression enhances barrier 
function. In fact, recent studies analyzing the physiological function of TRIC revealed that the 
presence of the protein in bTJ reduces strand discontinuities, increases paracellular electrical 
resistance and decreases permeability to ions and larger solutes, but without change in ion 
selectivity or charge preference (Krug et al., 2009). At tricellular contacts, TRIC specifically 
seals epithelial cell sheets against passage of macromolecules without significantly affecting 
ion permeation (Fig. 4). This property was explained by the fact that tricellular central tubes 
are wide enough for passage of macromolecules, but too rare to contribute significantly to ion 
permeability (Krug et al., 2009).  
 
Fig. 4. Squematic drawing of epithelial cells. In the uppermost of epithelial cells, tricellulin appears to be involved 
in sealing tricellular contacts, forming the central tube, which controls the paracellular flux of macromolecules.  
 
          In this context, the tricellular central tubes represent an attractive target to enhance 
delivery of drug molecules across epithelial and endothelial barriers. It should be noted that 
TRIC and occludin knockdown are different from a recently published report, which showed 
no decreases in baseline or peak transendothelial electrical resistence (TER) (Raleigh et al., 
2010). One possible explanation is the fact that Raleigh et al (2010) was used different kind 
of cell line for its experiments. In fact, transport and metabolic properties of cultured cells can 
vary due to culture conditions, seeding density, passage number, confluence, filter support, 
monolayer age, and stage of differentiation (Volpe, 2007). Moreover, during transport 
experiments, cell absorption properties can change due to the composition and pH of the 
transport buffer, solute concentration and solubility, temperature, additives and/or cosolvents, 
agitation, sampling schedule, sink conditions, and analytical methods (Volpe, 2007). 
          The first marker of the tTJ, TRIC, was recently identified in human nasal epithelial cells 
also, in vitro and in vivo, by Ohkuni et al., (2009). They described that TRIC expression is 
stable in human nasal epithelial cells and may play an important role for the sealing of the 
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corner at tricellular contacts to prevent infiltration by various inhaled viruses and antigens. In 
addition, it was reported that TJ molecules in human nasal epithelial cells in part function via 
PKC signaling pathway. Recent study in human nasal epithelial suggest that peroxisome 
proliferator activated receptor (PPARγ) agonists, a nuclear hormone receptor superfamily 
member and a ligand-activated transcription are involved in the barrier functions and in the 
upregulation of TJ molecules in gastrointestinal epithelial cells, EC and urothelial cells (Varley 
et al., 2006; Huang et al., 2009). Investigators thought that these PPARγ agonists induces 
claudin-1, claudin-4, occludin and TRIC molecules, and enhances TJ barrier function. 
Furthermore, the PPARγ agonists affect a PKC signal transduction pathways, increasing 
phospo-panPKC activity (Ogasawara et al., 2010). 
3. 3. 1. Mutations in tricellulin gene 
          To date, four human TRIC isoforms have been described (Riazuddin et al., 2006). Tric-
a is the longest isoform (558 aa) that contains seven exons and has a C-terminal ELL 
sequence with 51% similarity to occludin. The isoform Tric-a1 lacks the exon three and Tric-b 
is a shorter isoform (458 aa) that was reported to be cloned from human lung, mammary 
gland, and eye mRNA, lacking the occludin-ELL domain of. The occurrence of Tric-b is 
hypothesized in basal cell layers of keratinocyte cultures (Schlüter et al., 2007). The last 
isoform, Tric-c (442 aa), which was cloned from mRNA isolated from human lung, is predicted 
to be a two-transmembrane domain protein with an alternatively spliced exon two. For 
mouse, three TRIC isoforms were described: Tric-a is the longest isoform that contains eight 
exons. The isoforms Tric-b and Tric-c have a shorter transmembrane domain protein (Fig. 5.). 
 
Fig. 5. Alternative splice isoforms of Human and mouse tricellulin (TRIC). The TRIC mRNA has seven exons and 
four alternative splice isoforms for Human (Tric-a, Tric-a1, Tric-b and Tric-c), while mouse (Tric-a, Tric-b and Tric-
c) has three. The blue dotted bars below exon 2 indicatethe localization of predicted transmembrane helices. The 
red dotted lines below exons 5, 6 and 7 indicate the occludin-ELL domain.  
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          TRIC assembly at tTJ in cochlear and vestibular epithelial cells appears to play a key 
role in hearing, as mutations in the TRIC gene were associated with deafness (Riazuddin et 
al., 2006). It is known that TRIC protein is present at tricellular contacts of vestibular and 
cochlear epithelia and mutations of TRIC-a, the longest human isoform, have been reported 
to result in a human hereditary disease, nonsyndromic deafness (DFNB49). A common 
feature of the four DFNB49 TRIC alleles is that they encode predicted truncated proteins that 
lack the ability to bind to the scaffolding protein ZO-1, because of the loss of the conserved 
C-terminal occludin-ELL domain, and as previously described, this can interfere with the 
localization to TJs. In contrast, Raleigh, et al., (2010) suggested that TRIC may interact with 
ZO-1 at another site, because their studies show that C-terminus of TRIC was not able to 
bind ZO-1 GK domain. Alternatively, minor differences between the TRIC tails constructs 
used in both studies may explain the disparate observations. In fact, it has been speculated 
the relation between mutations in TJ gene and deafness. Mutations in claudin 14 gene are 
associated with different hearing thresholds, including profound and congenital deafness, but 
the role of this protein in hearing process is still unknown (Bashir et al., 2010; Ben-yosef et 
al., 2003). Yet, the only obvious phenotype of mutant alleles of Tric is deafness. It is possible 
that some other molecule compensates for the absence of wild-type TRIC in other epithelial 
cell types but not in the inner ear. 
3. 4. Expression of tricellulin in non-epithelial cells 
          In spite of having reports dealing with expression of integral plasma membrane 
proteins specifically located at TJ like occludin, in primary cultures of neurons and astrocytes, 
particularly in undifferentiated state (Bauer et al., 2009), and despite the similar ectodermic 
origin of nervous tissue, TRIC presence in nerve cells has been underestimated, as it was 
only shown its expression by Northen blot analysis of mouse brain homogenates (Ikenouchi 
et al., 2005). Of interest is the TRIC mRNA expression in mature dendritic cells (Ogasawara 
et al., 2009). The mRNA expression of TRIC in human monocytes cell line THP-1, together 
with the presence of occludin, claudin-1 and ZO-1 in dendritic cells (Ogasawara et al., 2009), 
point to the establishment of TJ-like structures between dendritic and epithelial cells, which 
shall preserve the integrity of the epithelial barrier upon antigen sampling. The observation of 
such a role in the gut defense against bacteria, raises the question of whether TRIC also 
contributes to the brain immune system, namely through the resident immunocompetent 
cells, microglia. 
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          Barrier induction involves multiple agents and cell types (Cardoso et al., 2010; Carvey 
et al., 2009). However, nothing has ever been demonstrated about the influence of neuronal 
or non-neuronal brain cells on tricellular junctions between BMEC. On the other hand, the 
expression of tricelluliin brain neural cells has never been investigated, despite the several 
lines of evidence indicating the presence of TJ proteins in CNS cells.  
Establishment of the cellular profile of TRIC expression in the brain shall provide valuable 
information about the neurovascular unit that ultimately shall open new opportunities for the 
development of new therapeutic strategies for prevention and treatment of central nervous 
system disorders.  
4. Aim 
          The absence of reports about the expression of TRIC in the endothelial cell of brain 
capillaries, as in the other cells of the unit neurovascular, prompted us to investigate whether 
TRIC is present in human and in a rat brain. The precise and specific localization of TRIC in 
cells sites will be examined in cultures of HBMEC, as well as in the brain in situ. To establish 
the cell types of neurovascular unit expressing the protein, we will search the presence of 
TRIC in primary culture of rat microglia and neurons, already in use in our laboratory. The 
localization of TRIC will be highlighted by immunohistochemical and immunocytochemical 
methodologies, while the quantitative expression of the TRIC mRNA e respective protein will 
be determined by real-time PCR and western blot analysis, respectively.  
          By revealing the presence of TRIC in human brain, this study shall have an important 
impact in the field of cerebral vascular biology and opens new avenues for future research, 
namely on the role of TRIC in nerve cells. 
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 1. Human and rat samples 
          Human stomach paraffin sections were obtained from the files of the department of 
pathological anatomy of the Hospital São José. As human brain sample it was used 
discarded temporal lobe tissue obtained during neurosurgical operative procedure for 
treatment for intractable epilepsy, after informed consent and approval by the Ethics 
Commission of the Hospital Santa Maria, Lisbon.  
          Animal care followed the recommendations of European Convention for the Protection of 
Vertebrate Animals Used for Experimental and other Scientific Purposes (Council Directive 
86/609/EEC) and National Law 1005/92 (rules for protection of experimental animals). All 
animal procedures were approved by the Institutional Animal Care and Use Committee. 
Every effort was made to minimize the number of animals used and their suffering. 
2. Tissues samples preparation 
2. 1. Human 
          Sections of human stomach were analyzed as a guarantee of the use of proper 
experimental protocols, since the presence of TRIC in the gastric epithelium was already 
reported (Ikenouchi et al., 2005).  
          Brain and stomach tissue was formaldehyde-fixed and, following macroscopic 
assessment, was paraffin embedded, sectioned at 2 m and mounted on microscope slides 
Superfrost® Plus (Thermo Scientific, Soeborg, Denmark) were then processed for 
immunohistochemical and immunofluorescence reactions. 
2. 2. Rat 
          Wistar rats were sacrified by decapitation, under deep anesthesia. The brain was 
enucleated immediately, placed in a Petri dish containing ice-cold PBS and dissected. Tissue 
for histology was prepared as described above for human samples. 
3. Cells Culture 
3. 1. Primary cultures of human brain microvascular endothelial cells  
          Isolation and culture of HBMEC were performed as usual in our lab (Bernas et al., 
2010). Briefly, the meninges and the white matter were removed from the brain tissue piece. 
The tissue was fragmented and homogenized, and the suspension was filtered through a 
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polyester mesh with 500 µm pore-size. The collected pass-through fluid was filtered using a 
30 µm mesh and the retained fragments were washed out. The microvascular fragments 
retained were ressuspended in isolation medium (DMEM/Ham‟s F12 supplemented with 10 % 
FBS, 1 % glutamax and 1 % antibiotic-antimycotic solution) and centrifuged at 30 g for 10 
min. The cellular pellet was ressuspended in 4 ml of isolation supplemented medium with 50 
µg/ml ECGS and 1 mg/ml heparin and then transferred to a collagen type I T-25 flask. The 
flask was incubated at 37 °C in a humid atmosphere enriched with 5 % CO2. Cells were 
monitored under contrast phase microscopy. At confluence, HBMEC were obtained by mild 
trypsinization with a trypsin-EDTA solution (0.05% trypsin, 0.02% EDTA in Hank‟s balanced 
salt solution) for 5 minutes at 37 ºC. All fluid containing cells was harvested and centrifuged at 
30 g for 10 minutes and then the pellet was resuspended in 4 ml of isolation supplemented 
medium. The suspension was plated in a T-25 flask and in a 6 well plate (2 ml), previously 
coated with 2.5 ml or 0.8 ml collagen type I, respectively. 
3. 2. Culture of human brain microvascular endothelial cell line 
          A cell line of HBMEC that showed to maintain morphologic and functional characteristics 
(Stins et al, 1997) were used. Cryopreserved cells were cultured in RPMI medium 
supplemented with 10 % FBS, 10 % NuSerum IV, 1 % NEAA, 1 % MEMvitamins, 1 mM 
sodium pyruvate, 2 mM L-glutamine and 1 % antibiotic-antimycotic solution (cell line 
medium). The HBMEC line was seeded at a density of 100 x 103 cell/ml in collagen I-coated 
plates and used after 48 hours in culture. 
3. 3. Primary cultures of rat microglia and neurons  
          Mixed glial cultures were prepared from 1–2 day-old Wistar rats as previously 
described (McCarthy and de Vellis, 1980), with minor modifications, as usual in our lab 
(Gordo et al., 2006). Cells were maintained in culture until 21 days and microglia were 
isolated by mild trypsinization, as previously described by Saura et al. (2003). The use of 21 
days in vitro (DIV) cells intents to achieve the maximal yield and purity of the cultures. 
Microglia were obtained for western blot, immunocytochemistry and RNA isolation for real-
time PCR analysis.  
          Neurons were isolated from foetuses of 17–18-day pregnant Wistar rats, as previously 
described (Silva et al., 2002a). Neurons at 3 DIV were obtained for western blot, 
immunocytochemistry and RNA isolation for real-time PCR analysis. 
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4. Immunohistochemistry  
          Immunostaining was performed in buffered formaldehyde-fixed embedded tissue 
sections. After the deparaffinization and rehydration procedures, the sections were rinsed in 
distilled water for 5 minutes and then a 3% H2O2 solution was used; following the inhibition of 
endogenous peroxidase, an antigen recovery was achieved by treatment with citrate buffer 
for 30 minutes at high temperature. After cooling  and washing, sections were directly 
incubated with primary antibody anti-tricellulin (1:30) for 1 hour at room temperature (RT), 
washed again in phosphate buffered saline (PBS) and incubated with EnVision detection 
system for 1 hour at RT. Finally, the sections were developed in 3,3‟-diaminobenzidine 
tetrahydrochloride and H2O2 solution and were counterstained with Mayer‟s hematoxylin. 
Images were acquired with a confocal microscope (Zeiss, LSM 510) or an upright microscope 
fitted with widefield epifluorescence (Zeiss, model Scope.A1) with an integrated digital 
camera (Leica, model DFC490).  
          Immunofluorescence was performed as described above with minor modifications, 
required by this technique. After cooling and washing, sections were directly incubated 
overnight at 4 ºC with primary antibody anti-tricellulin (1:30), washed again in PBS, and 
incubated overnight at 4 ºC with Alexa Fluor® 488 goat anti-rabbit (1:500) secondary 
antibody. For nuclei staining was used DAPI in PBS (1:1000) during 30 minutes. 
5. Immunocytochemistry  
          Immunofluorescence analysis was performed in HBMEC plated on coverslips. When 
confluence was reached (after 48 hours in vitro for the cell line and after a few days for the 
primary culture), the culture medium was removed and cells were fixed with freshly prepared 
4% paraformaldehyde in PBS during 20 minutes at RT. After three rinses in PBS, cells were 
permeabilized with 0.5% Triton X-100 solution for 15 minutes. Following three washes in 
PBS, coverslips were blocked for 1 hour at RT using 3% BSA in PBS. Cells were incubated 
overnight at 4 ºC with the anti-tricellulin primary antibody (1:30) for EC and with anti-CD68 
antibody (1:100) to stain microglial cells and then with secondary antibodies Alexa Fluor® 
488 goat anti-rabbit and Alexa Fluor® 594 goat anti-mouse, respectively, were incubated at  
RT for 1 hour. Primary and secondary antibodies were diluted in blocking solution. For nuclei 
staining cells were incubated with Hoechst 33258 dye in PBS (1:1000) during 2 minutes. 
Following a final rinse in PBS and dehydration with methanol, coverslips were mounted onto 
uncoated glass slides with DPX medium. Slides were observed under an upright microscope 
fitted with widefield epifluorescence (Zeiss, model Scope.A1) equiped with an integrated 
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digital camera (Leica, model DFC490). Negative controls with omission of the primary 
antibody were performed in order to assure the results. 
6. Western blot analysis 
          For western blot analysis, total cell extracts were obtained in ice-cold 1x Cell Lysis 
Buffer plus 1nM phenylmenthylsulfonil fluoride (PMSF) and sonicated (Ultrasonic Processor 
UP100H, Hielscher-Ultrasound Technology, Teltow, Germany). The lysates were centrifuged 
at 14000g for 10 minutes, at 4 ºC, and the supernatants were collected and stored at -80 ºC. 
Protein concentrations were determined using microplate reader (PR 2100 Microplate 
Reader, Bio-Rad Laboratories). Proteins were denatured by boiling for 5 min in sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (0.125 M Tris-
HCl, 40% glycerol, 4% SDS, 1% β-mercaptoethanol and 0.2% bromo-phenol blue). Equal 
amounts of protein sample were separated on a polyacrylamide gel and transferred to a 
nitrocellulose membrane. Following transfer and blocking with a 5% milk solution, the blots 
were incubated overnight at 4 ºC with the primary antibodies rabbit anti-tricellulin (1:500) or 
mouse anti-β-actin (1:5000) diluted in blocking solution. After three washes with Tween20-
Tris buffered saline (T-TBS), the membranes were incubated with HorseRadish Peroxidase 
(HRP)-conjugated anti-rabbit or anti-mouse secondary antibodies for 1 hour at RT. 
Secondary antibodies were diluted in 5% BSA in T-TBS solution. After three washes with T-
TBS, chemiluminescent detection was performed by LumiGLO® and bands were visualized 
by autoradiography with Hyperfilm ECL. The intensity of the bands was quantified by 
scanning densitometry, standardized with respect to -actin and the protein levels were 
expressed as fold change. 
7. RNA isolation, reverse transcriptase and real-time PCR 
          Total RNA was extracted and purified from HBMEC, microglia and neurons using 
TRIzol® reagent and total RNA was quantified using Nanodrop ND-100 Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA). One microgram of total RNA was reverse 
transcribed into cDNA using a RevertAid Tm H Minus First Strand cDNA synthesis kit under 
the recommended conditions. Each cDNA synthesis was performed in a total volume of 20 µl 
for 60 min at 42 ºC and terminated by incubation for 5 min at 70 ºC. Real-time PCR detection 
(Applied Biosystems 7300 Fast Real-time PCR System, Applied Biosystem, Madrid, Espain) 
was performed using a SYBR Green qPCR Master Mix (2x). The PCR was performed in 
strips, each sample performed in triplicate, and a no-template control was included for each 
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amplificate. Standard curves using “calibrator” cDNA (chosen among the cDNA samples) 
were prepared for each target and reference gene. In order to verify the specificity of the 
amplification, a melt-curve analysis was performed, immediately after the amplification 
protocol. 
          Amplification products of each sample were analyzed in 2% agarose gel or 12% 
polyacrylamide gel after staining with ethidium bromide. Non-specific products of PCR were 
not found in any case. To provide a quantitative control for reaction efficiency, PCR analylis 
were performed with primers coding for the housekeeping gene β-actin. Primers used to 
detect β-actin and TRIC were obtained from Thermo Scientific (Soeborg, Denmark) and are 
indicated in Table 1. The sequences that were used as primers were checked using the 
primer3 and BLAST (Primer-BLAST, National Center for Biotechnology Information, Bethesda, 
USA). The relative quantification was made using the Pfaffl modification of the ∆∆Ct equation 
(Ct, cycle number at wich the fluorescence passes the threshold level of detection), taking 
into account the efficiencies of individual genes. The results were normalized to β-actin and 
the initial amount of the template of each sample was determined as relative expression 
versus one of the samples chosen as reference, in this case, HBMEC cell line sample. The 
relative expression of each sample was evaluated by the formula 2-∆∆Ct. ∆Ct is a value 
obtained, for each sample, by the difference between the mean Ct value of TRIC and the 
mean Ct value of β-actin. ∆∆Ct of one sample is the difference between its ∆Ct value and Ct 
value of the samples chosen as reference.  
Table 1. Primers sequences of tricellulin (TRIC) and of β-actin used to perform real-time PCR. The sequences 
were checked using the primer3 and BLAST (Primer-BLAST, National Center for Biotechnology Information, 
Bethesda, USA). 
 
Gene 
 
Forward primer 
 
Reverse primer 
 
Product size (bp) 
 
Tricellulin (MarvelD2) 
Rattus norvegicus 
 
 
TGAATGGCCACCAGTGACCGA 
 
AGTCAGGCATTACGATGGGCTTAG 
 
140 
β-actin 
Rattus norvegicus 
 
TCTTGCAGCTCCTCCGTCGC CCACCATCACACCCTGGTGCCTA 182 
Tricellulin (MarvelD2) 
Homo sapiens 
 
CGTGATGCCCGACTATGTGGC TCATGTTCCTGTCGGCTTTCCG 201 
β-actin 
Homo sapiens 
CAGAGCCTCGCCTTTGCCGA ATCCATGGTGAGCTGGCGGC 60 
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1. Analysis of tricellulin localization in human stomach in situ 
          There are studies which claim that the TJ protein TRIC does exist in sheets of mouse 
epithelial cells, such as in the stomach, and that it is localized at tricellular contacts (Ikenouchi 
et al., 2005). So, we started our studies by evaluation of the presence of TRIC in paraffin 
sections of human stomach.  When applying immunohistochemical analysis, our results 
showed that TRIC is concentrated at the tricellular contacts and distributed along bicellular 
contacts of epithelial gastric cells as well (Fig. 6 A, B). This observation confirmed the 
previously reported expression of TRIC in the stomach and assured that the optimal 
experimental conditions were established to seek for the presence of the protein in the brain. 
Interestingly, immunoperoxidase staining showed that this TJ protein is also present in the 
cytoplasm of the cells of immune system (Fig. 6 A).  
 
Fig. 6. Characterization of tricellulin (TRIC) in paraffin sections of human stomach by Immunohistochemical 
microscopy. (A) Immunoperoxidase staining shows TRIC protein (Brown) in gastric cells concentrated at the 
tricellular contacts (arrow) and distributed along bicellular contacts. TRIC is also presented in the cells of immune 
system (inset in A). (B) Immunofluorescence staining shows TRIC in the tricellular contacts (arrow). Scale bar: 40 
µm. 
2. Characterization of tricellulin distribution and expression in human brain 
microvascular endothelial cells  
          The presence of TRIC mRNA in mouse epithelium-derived tissue, such as the brain 
was referred by Ikenouchi et al. (2005). Subsequent studies, demonstrated the presence of 
the protein TRIC in epidermal and other stratified epithelial cells (Schlulter et al., 2007). 
Based on these observations we hypothesized that TRIC might be present in brain EC as 
well. So, we examined a cell line and primary cultures HBMEC for TRIC presence.  
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2. 1. Localization of tricellulin along intercellular junctions in a cell line of human brain 
microvascular endothelial cells   
          Human brain samples are difficult to obtain. So, we used a HBMEC line available in the 
laboratory. To characterize the presence of TRIC at tricellular or bicellular contacts, we 
performed immunofluorescence analysis of the HBMEC line, after 48 hours in vitro, when 
these cells formed monolayers. The precise and specific immunolocalization of TRIC among 
EC intercellular junctions were obtained by labeling TRIC hallmark protein. Our results 
showed that TRIC is concentrated at the tricellular contacts (Fig. 7 A) and also distributed 
along bicellular junctions between HBMEC (Fig. 7 B). 
 
Fig. 7. Characterization of tricellulin (TRIC) in a human brain microvascular endothelial cell line by 
immunofluorescence microscopy, after 48 hours in vitro. Scale bar: A, 20µm; B, 40µm. TRIC protein (green) is 
concentrated at the tricellular contacts (arrow) and distributed along bicellular tight junctions (arrowhead). Nuclei 
were stained with Hoechst 33258 dye (blue).  
2. 2. Protein and mRNA expression levels of tricellulin in a cell line and in primary 
cultures of human brain microvascular endothelial cells 
          We evaluated the TRIC protein expression in total lysates of HBMEC in a cell line and 
in primary culture by western blotting. Protein was extracted from the cell line and primary 
culture at confluence, achieved after 48 hours in vitro and after 15 DIV, respectively. Results 
showed that TRIC is expressed both in the cell line and primary culture of HBMEC (Fig. 8 A). 
Interestingly, TRIC protein expression is increased by 30% in the cell line compared to the 
primary culture, for the same amount of loaded protein (Fig. 8 B). We then examined the 
TRIC mRNA expression in the same samples by Real-time PCR technology. Our results 
showed TRIC mRNA expression in both HBMEC line and primary culture (Fig. 8 C). 
Comparing the expression of TRIC mRNA between the cell line and the primary culture, the 
TRIC / Hoechst TRIC / HoechstA B
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results were in consonance with those obtained for the protein expression. In fact, TRIC 
mRNA expression is increased in the cell line by 20% (Fig. 8 D).  
 
Fig. 8. Evaluation of tricellulin (TRIC) expression in human brain microvascular endothelial cells (HBMEC) in 
primary culture and a cell line. (A) Western-blot analysis – through use protein extracts from cell line and primary 
culture of HBMEC show a 64-kDa band corresponding to a protein of the predicted size for TRIC. (B) TRIC protein 
expression is increased in cell line compared to the primary culture. (C) Real-time PCR for TRIC and β-actin in cell 
line and in primary culture of HBMEC. The mRNA of TRIC is detected. M, 100-bp ladder DNA marker. (D) TRIC 
mRNA expression is increased in the cell line compared to the primary culture. The results were normalized to β-
actin and expressed as fold change over cell line. 
3. Assessment of tricellulin localization in rat and human brain in situ 
          Having established the presence of TRIC HBMEC, we next assessed the expression of 
this protein in the brain, in situ, by immunohistochemical analysis of paraffin sections. As 
stated earlier, human samples are difficult to obtain. Bearing this into account, the first 
analysis was performed in Wistar rat brain tissue – Immunoperoxidase staining showed that 
TRIC is present in the capillaries of rat brain (Fig. 9 A). Therefore, the detection of TRIC 
staining in situ confirms the presence of the protein observed in cultured brain EC. 
Interestingly, TRIC is also present in ependymal cells of the choroid plexus, where it is 
predominantly concentrated at bicellular contacts, though also present at three corner contact 
sites (Fig. 9 B).  
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Fig. 9. Immunohistochemical analysis of tricellulin (TRIC) in the rat brain. (A)  Immunoperoxidase staining of 
paraffin sections expressing TRIC protein in blood vessels. Higher amplification of blood vessels (inset in A). (B) 
TRIC is also present in choroid plexus and is predominantly concentrated at cell-cell contacts (arrow), though also 
present at tricellular contacts (arrowhead). Negative control with omission of the anti-TRIC antibody (inset in B). 
Scale bar: A, 150 µm; B, 100 µm. 
          Immunoperoxidase staining of paraffin sections of human brain revealed a brownish 
staining of the endothelial cell lining of blood vessels, thus demonstrating the expression of 
TRIC (Fig.10). This was confirmed by immunofluorescence analysis of the sections, which 
further showed that TRIC is predominantly concentrated at cell-cell contacts in blood vessels 
(Fig. 10 C, D). 
 
A B
Fig. 10. Immunohistochemical 
analysis of tricellulin (TRIC) in 
human hippocampus. (A) 
Immunoperoxidase staining of 
paraffin sections of human 
brain expressing protein in 
blood vessel (arrow). Higher 
amplification of blood vessels 
(inset in A). (B) Negative 
control with omission of the 
anti-TRIC antibody (C, D)  
Immunofluorescence staining 
in paraffin sections show TRIC 
protein (green) predominantly 
concentrated at tricellular 
contacts in blood vessels 
(arrows). Nuclei were stained 
with DAPI dye (blue in C and 
D). Scale bar: A,B, 40 µm; 
C,D, 150 µm.   
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4. Characterization of tricellulin in primary cultures of rat microglia and neurons 
          In 1999, Bauer et al. showed that occludin, a TJ-constituent molecule, is expressed in 
cultured astrocytes and neurons and they concluded that the abundant expression of occludin 
in neural cells in vitro is indicative of an “embryonic,” undifferentiated state. Furthermore, 
claudins and occludin expression was identified in human brain (Romanitan et al., 2007; 
Romanitan et al., 2010). These findings prompted us to examine the expression of TRIC in 
neurons. 
          Recently, it was reported the mRNA expression of TJ in cells of the immune system. In 
fact, mRNA of occludin, TRIC, JAM-A, ZO-1, ZO-2 and claudin -4, -7, -8, and -9 were 
detected in monocytic cells (Ogasawara et al., 2009). Accordingly, we observed TRIC 
expression in cells of the immune system in the stomach. On the other hand, microglia 
constitute the brain‟s immunocompetent cells and are intricately implicated in numerous 
inflammatory processes (Aloisi, 2001; Chew et al., 2006) included in neonatal brain injury 
(Gordo et al., 2006). These facts, led us to also investigate the presence of TRIC in microglia.  
4. 1. Examination of tricellulin mRNA expression in rat microglia and neurons 
We next proceeded to the evaluation of mRNA expression in primary cultures of rat microglia 
and neurons by real-time PCR analysis. As expected, mRNA TRIC expression was detected 
in all samples (Fig. 11 A), but with differences in the expression levels. In fact, TRIC mRNA 
expression is less expressed in microglia compared to neurons (~46%) as shown in Fig. 11 
B. However, the expression of the protein was not detected by western blot analysis of 
neurons and microglia, as well the expression of the protein by immunofluorescence analysis 
of neurons (data not shown).  
 
Fig. 11. Evaluation of the expression 
of tricellulin (TRIC) in rat neurons and 
microglia primary culture. (A) Real-
time PCR of rat neurons and 
microglia for β-actin and TRIC. The 
mRNAs of TRIC and β-actin are 
detected in all lanes. (NC) Negative 
control with omission of β-actin and 
TRIC cDNA, respectively. M, 100-bp 
ladder DNA marker. (B) TRIC mRNA 
expression is increased in neurons 
compared to the microglia. *p<0.05 
vs. neurons. 
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          In order to assess the relative expression of TRIC mRNA in non-endothelial with EC, 
we performed the comparative analysis of TRIC mRNA expression levels in neurons and 
microglia versus that found in the cell line of HBMEC. As shown in Fig. 14, TRIC mRNA is 
less expressed in neurons and microglia compared to HBMEC line (~7% and ~3, 
respectively), as would be expected based on the TJ attributes of the protein.  
 
Fig. 12. Comparative analysis of tricellulin (TRIC) mRNA expression between human brain microvascular 
endothelial  cells (HBMEC) line, rat neurons and microglia. TRIC mRNA is less expressed in neurons and 
microglia compared to HBMEC line. *p<0.01 vs. cell line. 
4. 2. Inspection of tricellulin localization in rat microglia  
          Based on the identification of TRIC mRNA expression in microglial cells, we next 
proceeded to identification of TRIC protein expression in primay culture of rat microglia by 
immunofluorescence microscopy, using specific markers for microglia and TRIC protein. 
Although the expression of the protein was not detected by western blot analysis, the results 
by immunofluorescence evidenced for the first time TRIC protein expressed on microglia 
cytoplasm: TRIC protein appears to be expressed in vesicles (Fig. 13).  
 
CD68 / Hoechst TRIC / Hoechst MergeA B C
Fig. 13. Characterization  of tricellulin 
(TRIC) in primary culture of rat 
microglia by immunofluorescence. 
(A) Staining of microglia expressing 
CD68 protein (red). (B) Staining of 
microglia expressing TRIC protein 
(green) in cytoplasm. (C) Double 
stained shows CD68 and TRIC 
protein expression. Nuclei were 
stained with Hoechst dye 33258 
(blue in A to C). Scale bar: 40 µm.  
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          In this study, we report, for the first time, the presence of the recently discovered TJ 
protein TRIC in HBMEC, both in cultured cells and in brain parenchyma in situ. We also show 
that the protein is specifically localized at tricellular contacts, though distributed along 
bicellular contacts as well. Moreover, this study is original in depicting the expression of TRIC 
within other cell types of the neurovascular unit. 
          The presence of TJ connecting EC is largely responsible for barrier function, which 
provides both anatomical and physiological protection for the CNS (Correale and Villa, 2009). 
TJ were identified for the first time in the 1960s (Brightman and Reese, 1969; Reese and 
Karnovsky, 1967). More recently, TJ have been divided in two types: TJ between two 
adjacent cells are called bTJ whereas at tricellular contacts, where there are three epithelial 
cells meeting together, there is a structurally specialized organization, named as tTJ 
(Ikenouchi et al., 2005). TRIC was the first tTJ protein identified at three corner contact sites 
(Ikenouchi et al, 2005). The majorative of the TRIC studies fall upon epithelial tissues, namely 
intestine, stomach and kidney, either in monolayer cell cultures or in situ. Despite the similar 
ectodermic origin of nervous tissue, and the several lines of evidence indicating the presence 
of TJ proteins in CNS cells, TRIC presence in the brain and particularly in nerve cells has 
been underestimated, as it was only shown its mRNA expression in mouse brain (Ikenouchi 
et al., 2005). Thus, in this study, we investigated the expression of TRIC in the human and rat 
brain and discriminated the cell types expressing the protein.  
 We started our studies by evaluating TRIC expression in human stomach, where the 
protein had previously been reported (Ikenouchi). By observing the presence of TRIC at 
tricellular contacts, as well as at bicellular contacts, between gastric epithelial cells we 
assured that the optimal experimental conditions to seek for the protein in the brain were 
established. Interestingly, in this preparatory study we detected TRIC expression in cells of 
the immune system. This observation, in line with the TRIC mRNA expression in mature 
dendritic cells reported by Ogasawara et al. (2009), further prompted us to look for TRIC 
expression in microglia, the brain resident immunocompetent cells (Chew et al., 2006; Streit, 
2002).  
          Our findings demonstrate that HBMEC, either in primary culture or in a well 
characterized cell line (Stins et al., 1997), expressed TRIC at both bicellular and tricellular 
contacts. This dual location of TRIC is in agreement with previous reports of TRIC location at 
both bTJ and at tTJ in different cell types (Ikenouchi et al., 2008; Ohkuni et al., 2009; Beese 
et al., 2010). In fact, Ikenouchi et al. (2008) reported that TRIC mislocates to bTJ to 
compensate for occludin loss and assumed that the loss of occludin does not affect TJ 
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organization, due to such loss of occludin does not affect TJ organization, due to such 
compensatory role of TRIC (Ikenouchi et al., 2008). On the other hand, studies performed by 
Ohkuni et al. (2009) claimed the presence of TRIC at bTJ, even with normal levels of 
occludin. Furthermore, a novel TJ protein of MARVEL family (marvelD3) was identified at 
bicellular and tricellular contacts (Raleigh et al., 2010). Since TRIC is one member of this 
family of proteins (Raleigh et al., 2010) and has structural similarity to occludin (Ikenouchi et 
al., 2005), our data showing the distribution of TRIC along bicellular as well as at tricellular 
contacts are consistent with the assumption that TRIC is not an exclusively tTJ. Moreover, 
based on the previously reported role of TRIC in the barrier properties of endothelial sheets 
(Ikenouchi et al., 2005; Krug et al., 2009) our results raise the hypothesis that TRIC may 
contribute to the BBB impermeability.  
          To better characterize TRIC expression in human brain endothelium, we studied both 
TRIC mRNA and protein expression in the cell line and in primary cultured HBMEC. The 
results obtained, showing mRNA expression together with protein expression in the two 
cellular systems, definitively demonstrated the presence of TRIC in endothelial cells of human 
brain microvasculature. The increased TRIC expression observed in the cell line, when 
compared to the primary culture, may result from the fact that properties of cultured cells can 
vary due to culture conditions, seeding density, passage number, confluence, filter support, 
monolayer age, and stage of differentiation (Volpe, 2007).  
          Having established the presence of TRIC in isolated HBMEC, we next assessed the 
expression of this protein in brain specimens by immunohistochemical analysis. In 
accordance with our results, TRIC protein is present in capillaries of rat brain, as well in 
human brain capillaries, therefore confirming the expression of the protein in the brain in situ. 
In addition, immunofluorescence analysis showed that TRIC is predominantly concentrated at 
cell-cell contacts. The use of rat brain sections also allowed the examination of choroid 
plexus for TRIC distribution. Interestingly, TRIC is also present in ependymal cells, where it is 
mainly found at bicellular contacts, though also present at three corner contact sites. It is 
known that at the blood-cerebrospinal fluid barrier, epithelial cells of choroid plexus have 
apical TJ, restricting intercellular passage of molecules (Correale and Villa 2009). Therefore, 
the presence of TRIC in ependymal cells of the choroid plexus may contribute to the barrier 
properties of the blood-cerebrospinal fluid barrier. 
          The expression of TRIC in brain neural cells has never been investigated, despite the 
fact that some TJ proteins have been reported in several brain cell types. In fact, Bauer et al. 
(1999) detected occludin in brain tissue, as well as in cultured neurons and astrocytes, 
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particularly in undifferentiated state, whereas Shimizu et al. (2008) found TJ molecules in 
pericytes. Furthermore, it was reported occludin expression by neuron and glial cells in 
human brain (Romanitan et al., 2007). Moreover, TJ not only provide structural integrity but 
also function as landmarks, spatially confining signaling molecules and polarity cues, as well 
as serving as docking sites for vesicles (Nelson, 2003). Given these facts, we hypothesized 
that TRIC might also be expressed in neurons and analyzed rat neurons in primary culture at 
3 DIV, which correspond to immature neurons (Falcão et al., 2006), for TRIC expression. The 
observation of TRIC mRNA expression, but not of protein expression, as assessed by 
western blot and immunofluorescence, may result from low expression levels of the protein, 
whereas the mRNA levels point to the capacity of neurons to retain, or even regain, some of 
their neuroepithelial characteristics throughout cultivation (Bauer et al. 1999). It is also 
conceivable that TRIC protein expression increases in neuropathological conditions, in an 
attempt to contribute to the barrier function. In fact, Brightman and Reese (1969) reported 
that, in a few instances, TJ are found between neuronal processes. Furthermore, occludin 
and claudins increase in Alzheimer‟s disease and vascular dementia‟s brains (Romanitan et 
al., 2007; Romanitan et al., 2010), pathologies associated with a disruption of the BBB 
(Zlokovic, 2008). 
          In respect to not detection TRIC protein expression in neurons, other explanations 
might be considerate: an existence of protein expression just in a few instances or a non 
existence of TRIC protein expression at all. In fact, both TRIC and occludin are located in 
tandem on human chromosome 5 and it has been speculated that they may have arisen from 
gene duplication during phylogenetic evolution (Steed et al., 2009). Consequently, it is 
possible that TRIC mRNA expression occurs without protein transcription or that TRIC protein 
is only expressed in some circumstances, like in those pathologies of the nervous system that 
lead to upregulation of occludin and claudins expression (Romanitan et al., 2007; Romanitan 
et al., 2010). 
          It is of interest the TRIC mRNA expression observed in mature dendritic cells 
(Ogasawara et al., 2009). The existence of intercellular junctions in cells of immune system, 
like mature dendritic cells and monocytes, point to the establishment of TJ-like structures 
between dendritic and epithelial cells, which shall preserve the integrity of the epithelial 
barrier upon antigen sampling (Ogasawara et al., 2009). It is believed that microglial cells 
derive from the monocyte/macrophage lineage (Alliot et al., 1999; Chan et al., 2007) and that 
they are capable to assume a phagocytic morphology when activated in response to 
disturbance of the CNS. Therefore, we also analyzed whether TRIC is expressed in these 
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brain immunocompetent cells. We detected mRNA for TRIC and, most surprisingly, an 
exuberant protein expression, as revealed by immunofluorescence analysis. Therefore, the 
microglia potential to produce TRIC raises the hypothesis that this TJ protein may somehow 
contribute to the brain immune system. 
          We also compared the values of TRIC mRNA expression in endothelial and non-
endothelial cells. This preliminary comparison showed that the mRNA expression was 
remarkably higher in HBMEC when compared to the other NVU cells. These results would be 
anticipated by the endothelial cell nature of HBMEC and are in accordance with the fact that 
TJ are mostly present in epithelial cells.  
          Unfortunately, due to the difficult to obtain human samples and to the time spent in the 
optimization of experimental procedures, it was impracticable to perform more analysis in 
primary cultures of HBMEC and of rat microglia and neurons. 
          In conclusion, our experiments provide the first evidence that TRIC is present in brain 
microvascular endothelial cells, not only in tTJ, but also in bTJ. Thus, the presence of the 
protein in brain microvascular endothelium may contribute to the barrier properties of the 
BBB. Additionally, our findings suggest that TRIC is present in other than epithelial cells, 
namely neurons and microglia. This study opens new avenues for future research to 
understand the role of tricellulin in nerve cells, and to further characterize the protein 
expression by other cell types of the neurovascular unit, as well as its modulation by other 
brain cells. Moreover, the interactions between TRIC and other proteins, as well its regulation 
and mechanisms surely deserve to be further investigated.  
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1. Annex A 
1. 1. Chemicals 
          Collagen type I, endothelial cell growth supplement (ECGS) and Nuserum IV were 
acquired from BD Biosciences (Bedford, MA, USA). DPX mountant for microscopie, sodium 
dodecyl sulphate (SDS) was obtained from BDH Prolabo (Poole, UK). Hank‟s Balanced Salt 
Solution (HBSS), glutamax, TRIzol® Plus RNA Purification Kit, rabbit tricellulin monoclonal 
antibody, Alexa Fluor® 488 goat anti-rabbit IgG and Alexa Fluor® 594 goat anti-mouse IgG 
were purchased from Invitrogen™ (Carlsbad, CA, USA). Dulbecco‟s modified Eagle‟s 
medium/nutrient mixture Ham F-12 (DMEM/Ham‟s F12) minimum essential medium (MEM) 
with Earle‟s salts, HEPES [4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid] buffer, 
sodium pyruvate, fetal bovine serum (FBS), heparin solution, L-glutamine, Non-essential 
amino acids (NEAA) and sodium pyruvate were purchased from Biochrom AG (Berlin, 
Germany). Antibiotic-antimicotic solution (AB/AM), bovine serum albumin (BSA), Hoechst 
33258 dye, hydrocortisone (HC), Trypsin-EDTA solution (0.05% Trypsin, 0.02% EDTA in 
Hank‟s Balanced Salt Solution) and Roswell Park Memorial Institute (RPMI) 1640 were 
acquired from Sigma-Aldrich (St Louis, MO, USA). For protein quantification it was used the 
protein assay kit, acquired from BioRad (Hercules, California, CA). Nitrocellulose membrane, 
Hyperfilm ECL and HorseRadish peroxidase-labelled goat anti-mouse IgG were from 
Amersham Biosciences (Piscataway, NJ, USA). LumiGLO® was from Cell Signalling 
(Beverly, MA, USA). 3,3‟-diaminobenzidine tetrahydrochloride (Liquid DAB+ Substrate 
Chromogen System) and Dako REAL™ EnVision™ Detection System, Peroxidase/DAB, 
Rabbit/Mouse were obtained from DakoCytomation (Glostrup, Denmark) and Adcell Coated 
Printed Microscope slides were acquired from Thermo Scientific (Soeborg, Denmark). CD68 
monoclonal antibody was from AbD Serotec (Oxford, UK) and a HorseRadish peroxidase-
labelled goat anti-rabbit IgG was from Santa Cruz Biotechnology® (Santa Cruz, CA, USA). 
RevertAid Tm H Minus First Strand cDNA synthesis and Maxima SYBR Green qPCR Master 
Mix (2x) were obtained from Fermentas (Burlington, Ontario, Canada). Citrate buffer, high pH, 
was acquired from Vectashield, Vector Laboratories (Burlingame, CA, USA) and Superfrost® 
Plus from Thermo Scientific (Soeborg, Denmark). DAPI Acrylamide, bis-acrylamide, Tween 
20, hydrogen peroxide and hematoxylin, were from Merck (Darmstadt, Germany). All other 
chemicals were of analytical grade and were also from Merck. 
 
  
 
 
